Current Size: 100%

Seminar Lectures 2015


Invited Speakers:


Dr. Katerina Machova, PhD (September 4th, 2015)

Dr. Katerina Machova is Head of the Department of Molecular Genetics at the Institute of Hematology and Blood Transfusion in Prague. She is interested in mechansims of myeloid differentiation at progenitor levels. The clinical research focuses on tyrosine kinase inhibitors in patients with chronic myeloid leukemia (CML). Furthermore, she is investigating miRNA expression in CML patients. Her lecture was entitled “Molecular Studies on BCR/ABL and BCR/ABL-dependent Events in CML”. We thank her for her visit and the interesting data on BCR/ABL mutations in CML.


Prof. Stefan Fröhling (May 22nd, 2015)

Prof. Dr. Stefan Fröhling was invited to our Friday seminar on 22nd of May in 2015. He is a medical doctor and scientist at NCT/Universitätsklinikum Heidelberg, Deutsches Krebsforschungszentrum und Abteilung Medizinische Onkologie. The talked about "Expression and Role of CDK6 in Myeloid Leukemias" which was very interesting for our group.


Prof. Dr. Markus Manz (January 16th, 2015)

It was a pleasure to welcome Prof. Dr. Markus Manz from the University of Zurich. His research focuses on development, homeostasis and function of the haematopoietic- and the immune system, as well as on hemato-lymphoid diseases. His talk was entitled “Hematopoietic Stem and Progenitor Cell Response to Bacterial Stimuli”.


Prof. Andreas Reiter (January 15th, 2015)

Prof. Dr. Andreas Reiter was invited to give a talk at the joint seminar of the SFB F47-B20 and the Ludwig Boltzmann Cluster Oncology on Thursday, January 15th in 2015. He talked about “Biology, Diagnosis and Management of eosinophilic neoplasms”. Prof. Dr. Andreas Reiter is focusing on rare myeloproliferative neoplasms (MPN), such as chronic eosinophilic leukemia (CEL), hypereosinophilic syndrome (HES) as well as systemic Mastocytosis (SM). At the Medical Clinic III of the University of Mannheim in Germany he established an “Excellence Center for MPN”, where medical data from MPN patients are collected and evaluated.